NL-OMON39657已完成不适用
Early pharmacological intervention to prevent delirium: HAlopeRidol PrOphylaxis in Older emergency department patieNts. The HARPOON study - Haloperidol prophylaxis in older acutely admitted patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 780
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients aged 70 years or over;
- •- The patient is at increased risk for developing in-hospital delirium on admission according to one or more positive answers on the VMS delirium-risk questions;
- •- The patient or proxy is able to provide written informed consent;
- •- The patient or proxy speaks either Dutch or English;
- •- The patient is admitted to the hospital for an internal or surgical specialty.
排除标准
- •- Patients presenting in the ED with delirium according to the DSM-IV criteria;
- •- Patients with clinically significant (cardiac) disorders: QTc interval prolongation (QTc * 500ms), recent acute myocardial infarction, uncompensated heart failure (working diagnosis), acute coronary syndrome (ACS), arrhythmias treated with class IA and III antiarrhythmic medicinal products, history of ventricular arrhythmia, history of torsade de pointes, clinically significant bradycardia, second or third degree heart block, uncorrected hypokalaemia (potassium level 3.0 or lower);
- •- Patients with vascular dementia;
- •- Patients with Lewy Body dementia;
- •- Patients with Parkinson (dementia);
- •- Patients with (a history of) hypokinetic movement disorders;
- •- Patients with (a history of) malignant neuroleptic syndrome;
- •- Patients with (a history of) serotonergic syndrome;
- •- Patients with (a history of) central anticholinergic syndrome;
- •- Patients who will be admitted to the oncology ward;
- •- Patients who have been previously enrolled in the HARPOON study, or are currently enrolled in other medical- or drug (intervention) studies;
- •- Patients using co-medication of which concomitant use with haloperidol and/or during the 7-day intervention period according to protocol (SOP comedication) is contraindicated. Patients using QTc prolonging drugs at presentation with QTc *450ms (men) / QTc *460ms (women) on baseline ECG may be included in the study with repetitive ECG control according to protocol;
- •- Epilepsy
- •- Substance abuse and dependence (DSM-IV criteria)
- •- Patients who are not able to take study medication according to the protocol.
研究者
相似试验
进行中（未招募）
不适用
An early treatment with haloperiodl to prevent acute confusion in older patients who are acutely admitted to the hospital.DeliriumEUCTR2011-004762-15-NLVU Univeristy Medical Centre
尚未招募
不适用
Haloperidol prophylaxis in older emergency department patients.DeliriumNL-OMON21334VU Univeristy Medical Center Amsterdam600
已完成
4 期
Haloperidol Prophylaxis in Older Emergency Department PatientsDeliriumNCT01530308Amsterdam UMC, location VUmc242
已完成
不适用
Early Detection and Pharmacological Intervention for exercise-induced or cold-pressor-induced PHexercise-induced pulmonary hypertension, cold-pressor-induced pulmonary hypertensionJPRN-UMIN000029928Mie University Graduate School of Medicine Department of Cardiology and Nephrology50
招募中
不适用
Pharmaceutical-pharmacological interventions to improve drug therapy safety of inpatient carelow adherence, problems with drug application/use, patients' concerns regarding their drug therapyDRKS00026088Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik100